As a result, certain characteristics and diagnostic markers of a patient’s ovarian reserve, namely AMH, are used to identify the patients at risk of developing OHSS and individualize the starting dose of gonadotropin [8, 15]. Here, AMH is linked to ovarian hyperstimulation syndrome.